Transcutaneous Stimulation in Spinal Cord Injury
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- The Bronx, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 10 people enrolled
- Started
- 1 Jun 2022
- Ended
- 31 Jul 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- DS8R
- Record updated
- 22 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- above the age of 18 years old
- individuals with traumatic spinal cord injuries at or above T6; duration of injury if more than 1 year; non-ambulatory; American spinal injury association scale A, B or C
- able to provide consent
- non-ventilator
- hypotensive (males: systolic blood pressure less than 110 mmHg and/or diastolic blood pressure less than 70 mmHg; females: systolic blood pressure less than 100 mmHg and/or diastolic blood pressure less than 70 mmHg)
Who cannot take part
- acute illness or infection
- documented history of controlled or uncontrolled diabetes
- any other neurological disease other than spinal cord injury
- cardiovascular disease (coronary artery disease, congestive heart failure, peripheral artery disease, stroke)
- present of history of thrombosis in the last 12 months, severe contractures
- pregnant
Where in United States
- James J. Peters VA Medical Center, Bronx, NYThe Bronx, United States
About the trial
What the trial wants to find out
Cardiovascular disease has become the leading cause of death in the spinal cord injury population. Increased reliance on the renin-angiotensin-aldosterone system (RAAS) is believed to decrease falls in blood pressure when moving from a laying down position to upright; however, findings in the general population link the RAAS with remodeling and restructuring of the arterial walls. Therefore, intervention to stabilize and normalize blood pressure should be a priority in individuals with spinal cord injury who have low blood pressure. Advances in stimulation on the skin of the spinal cord offer an approach to restore cardiovascular control and improve blood pressure regulation; however, electrode placement and stimulation parameters needed to increase blood pressure are not well understood. Therefore, the aim of the study is to identify placement of electrodes on the skin, and frequency and amplitude of the stimulation to regulate blood pressure.
The 2 groups in the trial
- Without StimulationNo study treatment, for comparison
Seated blood pressure without transcutaneous spinal cord stimulation will be assessed.
- With StimulationExisting treatment, for comparison
Seated blood pressure with transcutaneous spinal cord stimulation will be assessed.
Treatment: DS8R
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Targeted Transcutaneous Stimulation to Restore Autonomic Cardiovascular Health in Veterans With Spinal Cord Injury
- Publications
- Record updated
- 22 September 2025